John P. Bilbrey

Insider Reports History

Location
New York, NY
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John P. Bilbrey:

Form 4 holding Director

TAPESTRY, INC.

Security class
Common Stock
Shares / value
47,846
Estimated value
$2,766,456
Report date
14 Nov 2024
Price
$57.82
Ownership
Direct
Form 4 holding Director

Elanco Animal Health Inc

Security class
Common Stock
Shares / value
78,400
Estimated value
$1,164,224
Report date
29 Nov 2024
Price
$14.85
Ownership
Direct
Form 4 holding Director

Elanco Animal Health Inc

Security class
Common Stock
Shares / value
41,722
Estimated value
$619,563
Report date
29 Nov 2024
Price
$14.85
Ownership
Revocable Trust
Form 4 holding Director

OLAPLEX HOLDINGS, INC.

Security class
Common Stock
Shares / value
318,418
Estimated value
$458,521
Report date
12 Aug 2025
Price
$1.44
Ownership
By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust
Form 4 holding Director

CAMPBELL SOUP CO

Security class
Phantom Stock
Shares / value
22,065
Estimated value
Report date
29 Sep 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

COLGATE PALMOLIVE CO

Security class
Stock Option (Right to Buy)
Shares / value
2,424
Estimated value
Report date
11 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John P. Bilbrey

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .